Literature DB >> 830618

Migraine therapy with heparin: pathophysiologic basis.

E Thonnard-Neumann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 830618     DOI： 10.1111/j.1526-4610.1976.hed1606284.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  6 in total

1.  Migraine responsive to warfarin: an update on anticoagulant possible role in migraine prophylaxis.

Authors:  F Maggioni; M Bruno; F Mainardi; C Lisotto; G Zanchin
Journal:  Neurol Sci       Date:  2012-01-06       Impact factor: 3.307

2.  Effect of intrapulmonary heparin on plasma diamine oxidase (histaminase) activity in mice.

Authors:  J Mahadoo; C J Wright; L B Jaques
Journal:  Agents Actions       Date:  1981-07

3.  Warfarin treatment and migraine.

Authors:  C G Suresh; D Neal; M O Coupe
Journal:  Postgrad Med J       Date:  1994-01       Impact factor: 2.401

Review 4.  Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?

Authors:  Mohammad Hassan A Noureldine; Ali A Haydar; Ahmad Berjawi; Rody Elnawar; Ahmad Sweid; Munther A Khamashta; Graham R V Hughes; Imad Uthman
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 5.  The Interplay Between Neuroinfections, the Immune System and Neurological Disorders: A Focus on Africa.

Authors:  Leonard Ngarka; Joseph Nelson Siewe Fodjo; Esraa Aly; Willias Masocha; Alfred K Njamnshi
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 8.786

Review 6.  Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms.

Authors:  Leonardo Biscetti; Gioacchino De Vanna; Elena Cresta; Ilenia Corbelli; Lorenzo Gaetani; Letizia Cupini; Paolo Calabresi; Paola Sarchielli
Journal:  J Neuroinflammation       Date:  2021-11-08       Impact factor: 8.322
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.